Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Although statins reduce cardiac events in hypertensive patients with cardiovascular risk
factors, the effect of statins on coronary flow reserve (CFR) has not been examined in such
patients. The investigators hypothesize that pitavastatin added to standard antihypertensive
therapy will be superior to placebo in improving CFR in hypertensive patients with
cardiovascular risk, and try to examine this hypothesis in a double-blind, randomized
comparison study using Doppler echocardiography.